Rising incidences of
various chronic illnesses such as cancer, HIV and cardiovascular diseases, innovative
and effective vaccines present in the healthcare industry and increasing
governmental funding for vaccine development are some of the factors proliferating
the demand of therapeutic vaccine, as per the market research report from
IndustryARC. The report has assessed the global therapeutic vaccine market valued
$19.62 billion in 2018. Furthermore, the market is projected to increase at a
CAGR of 36.52% during the forecast period 2019-2025.
The report is titled
“Therapeutic Vaccine Market: By Vaccine Type (Addiction, Neurological,
Infectious, and Autoimmune); By Technology (Autologous, Allogenic) and By
Region – Forecast (2019-2025).” It consolidates an in-depth analysis of the
imperative aspects of the market including market drivers, market value chain,
restraints, growth indicators, market trends, challenges, future outlook, and
market insights.
Therapeutic Vaccine
Market: Leading Segments
North America constitute
a dominant regional share accounted 46% of global market in 2018. Growing
initiatives by healthcare centers, improving recommended immunization, rising
adoption of advanced technology in healthcare, improved infrastructure and
increasing healthcare expenditure are some important factors that have rendered
North America with maximum demand share in the therapeutic vaccine market.
Therapeutic vaccine market
is segmented on basis of type into addiction vaccines, autoimmune disease
vaccines, cancer vaccines, infectious disease vaccines, neurological disease
vaccines and Parkinson’s disease vaccines. Among these, autoimmune disease
vaccines is found to be the major application segment. As per the recent
studies by American Autoimmune Related Diseases Association, autoimmune
diseases are affecting nearly 50 million Americans, boosting the usage of
autoimmune disease vaccine for treatment.[1] Resultantly,
key market players have capitalized on this application segment which is
expected to grow with a CAGR of 18% through to 2025.
Therapeutic Vaccine
Market Disruptive Trends
Certain number of
innovative technologies are being developed in accordance with the development
of new vaccines. Some of the latest disruptive trends are listed below:
· Single
injection systems with self-locking syringe:
It is designed to limit
the problem of reutilization of needles. This technology simplifies intradermal
injection by using a small needle than a conventional one. Furthermore, patches
comprising a set of micro-needles also used for intradermal injection are
currently under development. Single injection systems with self-locking syringe
technology is dominating the therapeutic vaccine market.
· Jet
Injector:
As per the studies of
Clinical, Cosmetic and Investigational Dermatology (CCID), jet injector is
gaining momentum in therapeutic vaccine market. All safety concerns associated
with needles are eliminated by jet injectors as vaccines are injected using gas
or air pressurized systems.
· Nasal
Vaccine:
The therapeutic vaccine
market has been disrupted by the development of alternate administration routes
namely nasal, intranasal, oral, topical, pulmonary, vaginal, and rectal. The
nasal route offers the most promising opportunity for vaccine administration.
It amplifies safety, convenience and elicit both local and systemic immune responses,
therefore providing protection from pathogens while vaccination.
Therapeutic Vaccine
Market: Competitive Landscape
Major companies
currently holding majority or market share in the global therapeutic vaccine
market are themare Cytos Biotechnology AG, Agenus, Inc., Pfizer, Merck &
Co., Dendreon Corp., GlaxoSmithKline, Biocon, Argos Therapeutic Inc., Novartis
AG and Celtic Pharma.
Talk to one of our sales
representative about the full report by providing your details in the link
below:
https://www.industryarc.com/support.php?id=
16292
Related Reports:
A. DNA
Vaccines Market
https://www.industryarc.com/Report/16032/dna-vaccines-market.html
B. Veterinary
Vaccines Market
https://www.industryarc.com/PressRelease/881/Veterinary-Vaccines-Market-Research.html
What can you expect from
the report?
The therapeutic vaccine
market is prepared with the main agenda to cover the
following 20 points:
1. Market Size by
Product Categories &
Application
11. Demand Analysis (Revenue
&
Volume)
2. Market trends &
Relevant Market
Data
12. Country level
Analysis
3. Manufacturer
Landscape
13. Competitor
Analysis
4. Distributor Landscape
14. Market
Shares Analysis
5. Pricing Analysis
15. Value
Chain Analysis
6. Top 10 End user
Analysis
16. Supply
Chain Analysis
7. Product Benchmarking
17. Strategic
Analysis
8. Product Developments
18. Current
& Future Market Landscape
Analysis
9. Mergers &
Acquisition Analysis
19.
Opportunity Analysis
10. Patent Analysis
20.
Revenue and Volume Analysis
Q. Does IndustryARC provide
customized reports and charge additionally for limited customization?
Response: Yes, we can customize the report by extracting
data from our database of reports and annual subscription databases. We can
provide the following free customization:
1. Increase the level of
data in application or end user industry.
2. Increase the number
of countries in geography chapter.
3. Find out market
shares for other smaller companies or companies which are of interest to you.
4. Company profiles can
be requested based on your interest.
5. Patent analysis,
pricing, product analysis, product benchmarking, value and supply chain
analysis can be requested for a country or end use segment.
Any other custom
requirements can be discussed with our team, drop an e-mail to [email protected] to discuss
more about our consulting services.
To request for a
proposal, provide your details in the below link:
https://www.industryarc.com/reports/request-quote?id=16292
Media Contact:
Mr. Venkat Reddy
Sales
Manager
Email 1:
[email protected]
Or Email 2:
[email protected]
Contact Sales:
+1-614-588-8538 (Ext-101)
About IndustryARC: IndustryARC is a research and consulting firm
that publishes more than 500 reports annually, in various industries such as
Agriculture, Automotive, Automation & Instrumentation, Chemicals and
Materials, Energy and Power, Electronics, Food and Beverages, Information
Technology, and Life sciences and Healthcare.
[1] https://www.aarda.org